Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


J Am Soc Nephrol 15: 2959-2964, 2004
© 2004 American Society of Nephrology
doi: 10.1097/01.ASN.0000145894.57533.C4

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giachelli, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giachelli, C. M.

REVIEWS

Vascular Calcification Mechanisms

Cecilia M. Giachelli

Bioengineering Department, University of Washington, Seattle, Washington.

Correspondence to Dr. Cecilia M. Giachelli, Bioengineering Department, Box 351720, University of Washington, Okanogan Lane, Bagley Hall, Seattle, WA 98195. Phone: 206-543-0205; Fax: 206-616-9763; E-mail: ceci{at}u.washington.edu

Vascular calcification is highly correlated with cardiovascular disease mortality, especially in patients with ESRD or diabetes. In addition to the devastating effects of inappropriate biomineralization seen in cardiac valvulopathies, calciphylaxis, and idiopathic arterial calcification, vascular calcification is now recognized as a marker of atherosclerotic plaque burden as well as a major contributor to loss of arterial compliance and increased pulse pressure seen with age, diabetes, and renal insufficiency. In recent years, several mechanisms to explain vascular calcification have been identified including (1) loss of inhibition, (2) induction of bone formation, (3) circulating nucleational complexes, and (4) cell death. Alterations in calcium (Ca) and phosphorus (P) balance as seen in patients with ESRD promotes vascular calcification via multiple mechanisms and may explain the alarmingly high levels of cardiovascular disease deaths in these patients. Strategies to control Ca and P levels in patients with ESRD have met with early success in preventing progression of vascular calcification. Whether or not vascular calcification can be reversed is not yet known, but exciting new studies suggest that this may be possible in the future.




This article has been cited by other articles:


Home page
NEJMHome page
M. Pazianas, A. B. Rossebo, T. R. Pedersen, Y. A. Kesaniemi, and C. M. Otto
Calcific Aortic Stenosis
N. Engl. J. Med., January 1, 2009; 360(1): 85 - 86.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Rodriguez-Garcia, C. Gomez-Alonso, M. Naves-Diaz, J. B. Diaz-Lopez, C. Diaz-Corte, J. B. Cannata-Andia, and the Asturias Study Group
Vascular calcifications, vertebral fractures and mortality in haemodialysis patients
Nephrol. Dial. Transplant., January 1, 2009; 24(1): 239 - 246.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
O. Cseprekal, E. Kis, P. Schaffer, T. E. H. Othmane, B. Cs. Fekete, A. Vannay, A. J. Szabo, A. Remport, A. Szabo, T. Tulassay, et al.
Pulse wave velocity in children following renal transplantation
Nephrol. Dial. Transplant., January 1, 2009; 24(1): 309 - 315.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
W. Noonan, K. Koch, M. Nakane, J. Ma, D. Dixon, A. Bolin, and G. Reinhart
Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats
Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3824 - 3830.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
E. Honkanen, L. Kauppila, B. Wikstrom, P. L. Rensma, J.-M. Krzesinski, K. Aasarod, F. Verbeke, P. B. Jensen, P. Mattelaer, B. Volck, et al.
Abdominal aortic calcification in dialysis patients: results of the CORD study
Nephrol. Dial. Transplant., December 1, 2008; 23(12): 4009 - 4015.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M.-u. Alam, J. P. Kirton, F. L. Wilkinson, E. Towers, S. Sinha, M. Rouhi, T. N. Vizard, A. P. Sage, D. Martin, D. T. Ward, et al.
Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells
Cardiovasc Res, November 6, 2008; (2008) cvn279v2.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Speer, B. Cs. Fekete, T. El Hadj Othmane, T. Szabo, J. Egresits, E. Fodor, I. Kiss, A. G. Logan, J. Nemcsik, A. Szabo, et al.
Serum osteoprotegerin level, carotid-femoral pulse wave velocity and cardiovascular survival in haemodialysis patients
Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3256 - 3262.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. J. Matias, C. Ferreira, C. Jorge, M. Borges, I. Aires, T. Amaral, C. Gil, J. Cortez, and A. Ferreira
25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients
Nephrol. Dial. Transplant., September 4, 2008; (2008) gfn502v1.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. A. Mandelbrot, P. W. Santos, R. K. Burt, Y. Oyama, G. A. Block, S. N. Ahya, R. M. Rosa, and A. E. Traynor
Resolution of SLE-related soft-tissue calcification following haematopoietic stem cell transplantation
Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2679 - 2684.
[Abstract] [Full Text] [PDF]


Home page
INT J LOW EXTREM WOUNDSHome page
U. Wollina, C. Helm, G. Hansel, A. Koch, J. Schonlebe, G. Haroske, and E. Kostler
Deep Ulcer Shaving Combined With Split-Skin Transplantation in Distal Calciphylaxis
International Journal of Lower Extremity Wounds, June 1, 2008; 7(2): 102 - 107.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. D. Morrisett and K. C. Vickers
Vascular Calcification in Homozygote Familial Hypercholesterolemia
Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 606 - 607.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Z. Awan, K. Alrasadi, G.A. Francis, R.A. Hegele, R. McPherson, J. Frohlich, D. Valenti, B. de Varennes, M. Marcil, C. Gagne, et al.
Vascular Calcifications in Homozygote Familial Hypercholesterolemia
Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 777 - 785.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Tanaka, H. Sato, H. Doi, C. A. Yoshida, T. Shimizu, H. Matsui, M. Yamazaki, H. Akiyama, K. Kawai-Kowase, T. Iso, et al.
Runx2 Represses Myocardin-Mediated Differentiation and Facilitates Osteogenic Conversion of Vascular Smooth Muscle Cells
Mol. Cell. Biol., February 1, 2008; 28(3): 1147 - 1160.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
D. L. Andress
Bone and Mineral Guidelines for Patients with Chronic Kidney Disease: A Call for Revision
Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 179 - 183.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. R. Wu-Wong, M. Nakane, J. Ma, X. Ruan, and P. E. Kroeger
Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1592 - F1604.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. Voormolen, M. Noordzij, D. C. Grootendorst, I. Beetz, Y. W. Sijpkens, J. G. van Manen, E. W. Boeschoten, R. M. Huisman, R. T. Krediet, F. W. Dekker, et al.
High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients
Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2909 - 2916.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. Molostvov, S. James, S. Fletcher, J. Bennett, H. Lehnert, R. Bland, and D. Zehnder
Extracellular calcium-sensing receptor is functionally expressed in human artery
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F946 - F955.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. H. Ix, G. M. Chertow, M. G. Shlipak, V. M. Brandenburg, M. Ketteler, and M. A. Whooley
Association of Fetuin-A With Mitral Annular Calcification and Aortic Stenosis Among Persons With Coronary Heart Disease: Data From the Heart and Soul Study
Circulation, May 15, 2007; 115(19): 2533 - 2539.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Meng, I. Vera, N. Che, X. Wang, S. S. Wang, L. Ingram-Drake, E. E. Schadt, T. A. Drake, and A. J. Lusis
Identification of Abcc6 as the major causal gene for dystrophic cardiac calcification in mice through integrative genomics
PNAS, March 13, 2007; 104(11): 4530 - 4535.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
M.-L. Gross, H.-P. Meyer, H. Ziebart, P. Rieger, U. Wenzel, K. Amann, I. Berger, M. Adamczak, P. Schirmacher, and E. Ritz
Calcification of Coronary Intima and Media: Immunohistochemistry, Backscatter Imaging, and X-Ray Analysis in Renal and Nonrenal Patients
Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 121 - 134.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. X. Chen, D. Duan, K. D. O'Neill, and S. M. Moe
High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells
Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3435 - 3442.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D J Rakhit, T H Marwick, K A Armstrong, D W Johnson, R Leano, and N M Isbel
Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease
Heart, October 1, 2006; 92(10): 1402 - 1408.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. R. Wu-Wong, W. Noonan, J. Ma, D. Dixon, M. Nakane, A. L. Bolin, K. A. Koch, S. Postl, S. J. Morgan, and G. A. Reinhart
Role of Phosphorus and Vitamin D Analogs in the Pathogenesis of Vascular Calcification
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 90 - 98.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
D. A. Bushinsky
Phosphate Binders: Hold the Calcium?
Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 695 - 696.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. Yuen, A. Pierratos, R. M.A. Richardson, and C. T. Chan
The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients
Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1407 - 1412.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. L. Demer and Y. Tintut
Pitting Phosphate Transport Inhibitors Against Vascular Calcification
Circ. Res., April 14, 2006; 98(7): 857 - 859.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. P. Schmitt, T. Odenwald, and E. Ritz
Calcium, Calcium Regulatory Hormones, and Calcimimetics: Impact on Cardiovascular Mortality
J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S78 - S80.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
M. E. Williams
Coronary Revascularization in Diabetic Chronic Kidney Disease/End-Stage Renal Disease: A Nephrologist's Perspective
Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 209 - 220.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
I. Lopez, E. Aguilera-Tejero, F. J. Mendoza, Y. Almaden, J. Perez, D. Martin, and M. Rodriguez
Calcimimetic R-568 Decreases Extraosseous Calcifications in Uremic Rats Treated with Calcitriol
J. Am. Soc. Nephrol., March 1, 2006; 17(3): 795 - 804.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Ketteler, V. Brandenburg, W. Jahnen-Dechent, R. Westenfeld, and J. Floege
Do not be misguided by guidelines: the calcium x phosphate product can be a Trojan horse
Nephrol. Dial. Transplant., April 1, 2005; 20(4): 673 - 677.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP